title: Liraglutide and Cardiometabolic Effects: More than Just Another Antiobesity Drug?
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Georgios A
authors.initials: GA
authors.lastname: Christou
authors.affiliation: Laboratory of Physiology, Medical School, University of Ioannina, 45110 Ioannina, Greece. dkiorts@cc.uoi.gr.
authors.forename: Dimitrios N
authors.initials: DN
authors.lastname: Kiortsis
mesh_terms: D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D009765:Obesity / Q000188:drug therapy*
chemical_list: D007004:Hypoglycemic Agents; D052216:Glucagon-Like Peptide 1